Highlights

  • Genetic Technologies reported cash and cash equivalents of just $10,000 as at 30 June 2026, with total available funding limited to that amount.
  • All operating, investing and financing cash flows were reported at zero for both the quarter and the year to date.
  • The company remains subject to a Deed of Company Arrangement, executed on 19 March 2025 following a creditor vote on 27 February 2025.
  • Every major operating category, including research, manufacturing, Marketing and staffing, reported zero activity and zero cash outflow during the quarter.

Genetic Technologies Limited (ASX:GTG) has lodged its Appendix 4C and quarterly activities report for the June 2026 quarter, showing a company with essentially no operational activity and just $10,000 in cash remaining. The filing reflects the company's continued status under a Deed of Company Arrangement following its entry into voluntary administration in late 2024.

A Quarter With No Operating Activity

The quarterly Cash Flow report shows operating, investing and financing activities all recorded at zero, both for the June 2026 quarter and on a year-to-date basis. Every major operating category typically reported in these filings, including research, manufacturing, marketing and staffing costs, showed zero activity and zero cash outflow. The only cash movement noted was a minimal amount, described as approximately $100 (reported in the filing as $0,100k), related to residual administration and corporate costs. No related party payments were made during the quarter.

With cash and cash equivalents standing at $10,000 as at 30 June 2026, and no unused financing facilities available, the company's total available funding is limited to that same $10,000 balance. This leaves Genetic Technologies with negligible financial resources beyond what is required to maintain its administrative status.

Background: Administration and the Deed of Company Arrangement

Genetic Technologies entered voluntary administration on 20 November 2024, with Ross Blakeley and Paul Harlond of FTI Consulting appointed as administrators. Creditors voted on 27 February 2025 to enter a Deed of Company Arrangement, which was subsequently executed on 19 March 2025. The company's continued filing of quarterly Appendix 4C reports, despite having no underlying operations, reflects its ongoing obligations as an ASX-listed entity while the terms of the Deed of Company Arrangement are worked through.

Conclusion

This quarter's filing confirms that Genetic Technologies (ASX:GTG) remains dormant, with no operating activity, no material cash movements, and only $10,000 in available funds as at 30 June 2026. The company's position continues to be governed by the Deed of Company Arrangement executed in March 2025, and there is little in this report to suggest a near-term change in status. Shareholders and other Market Participants may want to watch for any future announcement regarding progress or resolution of the Deed of Company Arrangement, as that would be the more likely trigger for a change in the company's circumstances rather than anything in this quarter's routine filing.